Increased specific T cell cytokine responses in patients with active pulmonary tuberculosis from Central Africa

Microbes and Infection

Volumn 7, Issue 9-10, 2005, Pages 1161-1169

  Winkler, Stefan ^a,c   Necek, Magdalena ^a,c   Winkler, Heidi ^a,c   Adegnika, Ayola A ^b,c   Perkmann, Thomas ^a   Ramharter, Michael ^a,b,c   Kremsner, Peter G ^b,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c ALBERT SCHWEITZER HOSPITAL   (Gabon)

Author keywords

Central Africa; Cytokines; Mycobacterium tuberculosis; PPD; Pulmonary tuberculosis

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CENTRAL AFRICA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FREQUENCY ANALYSIS; HOST RESISTANCE; HUMAN; HUMAN CELL; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD3; BREFELDIN A; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; FEMALE; GABON; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; IONOMYCIN; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; TUBERCULIN; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

MYCOBACTERIUM TUBERCULOSIS;

EID: 24944444326     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.03.020     Document Type: Article

References (61)

1. E.L. Corbett, C.J. Watt, N. Walker, D. Maher, B.G. Williams, M.C. Raviglione, and C. Dye The growing burden of tuberculosis: global trends and interactions with the HIV epidemic Arch. Intern. Med. 163 2003 1009 1021
2. J.M. Tufariello, J. Chan, and J.L. Flynn Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection Lancet Infect. Dis. 3 2003 578 590
3. + T cells in human tuberculosis Proc. Natl. Acad. Sci. USA 97 2000 12210 12215
4. + T cells preferentially recognize heavily infected cells Am. J. Respir. Crit. Care Med. 168 2003 1346 1352
5. U.E. Schaible, F. Winau, P.A. Sieling, K. Fischer, H.L. Collins, and K. Hagens Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis Nat. Med. 9 2003 1039 1046
6. W.H. Boom Gammadelta T cells and Mycobacterium tuberculosis Microbes Infect. 1 1999 187 195
7. + T cells during mycobacterial infections Science 295 2002 2255 2258
8. I.M. Orme, A.D. Roberts, J.P. Griffin, and J.S. Abrams Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection J. Immunol. 151 1993 518 525
9. J.L. Flynn, J. Chan, K.J. Triebold, D.K. Dalton, T.A. Stewart, and B.R. Bloom An essential role for interferon δ in resistance to Mycobacterium tuberculosis infection J. Exp. Med. 178 1993 2249 2254
10. J. Chan, Y. Xing, R.S. Magliozzom, and B.R. Bloom Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages J. Exp. Med. 175 1992 1111 1116
11. J. Chan, K. Tanaka, D. Carroll, J. Flynn, and B.R. Bloom Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis Infect. Immun. 63 1995 736 740
12. E.A. Rich, M. Torres, E. Sada, C.K. Finegan, B.D. Hamilton, and Z. Toossi Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB Tuber. Lung Dis. 78 1997 247 255
13. J.D. MacMicking, G.A. Taylor, and J.D. McKinney Immune control of tuberculosis by IFN-δ-inducible LRG-47 Science 302 2003 654 659
14. M.J. Newport, C.M. Huxley, S. Huston, C.M. Hawrylowicz, B.A. Oostra, R. Williamson, and M. Levin A mutation in the interferon-δ-receptor gene and susceptibility to mycobacterial infection N. Engl. J. Med. 335 1996 1941 1949
15. C. Picard, C. Fieschi, F. Altare, S. Al-Jumaah, S. Al-Hajjar, and J. Feinberg Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds Am. J. Hum. Genet. 70 2002 336 348
16. J. Vilcek, A. Klion, D. Henriksen-DeStefano, A. Zemtsov, D.M. Davidson, and M. Davidson Defective δ-interferon production in peripheral blood leukocytes of patients with acute tuberculosis J. Clin. Immunol. 6 1986 146 151
17. F.O. Sanchez, J.I. Rodriguez, G. Agudelo, and L.F. Garcia Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls Infect. Immun. 62 1994 5673 5678
18. M. Zhang, Y. Lin, D.V. Iyer, J. Gong, J.S. Abrams, and P.F. Barnes T-cell cytokine responses in human infection with Mycobacterium tuberculosis Infect. Immun. 63 1995 3231 3234
19. J.H. Gong, M. Zhang, R.L. Modlin, P.S. Linsley, D. Iyer, Y. Lin, and P.F. Barnes Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression Infect. Immun. 64 1996 913 918
20. A. Sodhi, J. Gong, C. Silva, D. Qian, and P.F. Barnes Clinical correlates of interferon-δ production in patients with tuberculosis Clin. Infect. Dis. 25 1997 617 620
21. C.S. Hirsch, Z. Toossi, G. Vanham, J.L. Johnson, P. Peters, and A. Okwera Apoptosis and T cell hyporesponsiveness in pulmonary tuberculosis J. Infect. Dis. 179 1999 945 953
22. C.S. Hirsch, Z. Toossi, C. Othieno, J.L. Johnson, S.K. Schwander, and S. Robertson Depressed T-cell interferon-δ responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy J. Infect. Dis. 180 1999 2069 2073
23. T. Hertoghe, A. Wajja, L. Ntambi, A. Okwera, M.A. Aziz, and C. Hirsch T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB) Clin. Exp. Immunol. 122 2000 350 357
24. A.A. Pathan, K.A. Wilkinson, P. Klenerman, H. McShane, R.N. Davidson, and G. Pasvol Direct ex vivo analysis of antigen-specific IFN-δ-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment J. Immunol. 167 2001 5217 5225
25. J. Vekemans, C. Lienhardt, J.S. Sillah, J.G. Wheeler, G.P. Lahai, and M.T. Doherty Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia Infect. Immun. 69 2001 6554 6557
26. J. Vekemans, M.O. Ota, J. Sillah, K. Fielding, M.R. Alderson, and Y.A. Skeiky Immune responses to mycobacterial antigens in the Gambian population: implications for vaccines and immunodiagnostic test design Infect. Immun. 72 2004 381 388
27. A. Demissie, M. Abebe, A. Aseffa, G. Rook, H. Fletcher, and A. Zumla Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4δ2 J. Immunol. 172 2004 6938 6943
28. C.B. Pereira, M. Palaci, O.H. Leite, A.J. Duarte, and G. Benard Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations Microbes Infect. 6 2004 25 33
29. H.M. Surcel, M. Troye-Blomberg, S. Paulie, G. Andersson, C. Moreno, and G. Pasvol Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens Immunology 81 1994 171 176
30. + T cells in active pulmonary tuberculosis Chest 111 1997 606 611
31. V.A. Boussiotis, E.Y. Tsai, E.J. Yunis, S. Thim, J.C. delgado, and C.C. Dascher IL-10-producing T cells suppress immune responses in anergic tuberculosis patients J. Clin. Invest. 105 2000 1317 1325
32. + T cells from patients with tuberculosis is related to the presence of pulmonary cavities J. Infect. Dis. 181 2000 1194 1197
33. A.C. Cubillas-Tejeda, A. Ruiz-Arguelles, G. Bernal-Fernandez, L. Quiroz-Compean, A. Lopez-Davila, and E. Reynaga-Hernandez Cytokine production and expression of leucocyte-differentiation antigens by human mononuclear cells in response to Mycobacterium tuberculosis antigens Scand. J. Immunol. 57 2003 115 124
34. X. Bai, S.E. Wilson, K. Chmura, N.E. Feldman, and E.D. Chan Morphometric analysis of Th(1) and Th(2) cytokine expression in human pulmonary tuberculosis Tuberculosis (Edinb.) 84 2004 375 385
35. M.G. Bonecini-Almeida, J.L. Ho, N. Boechat, R.C. Huard, S. Chitale, and H. Doo Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-β) and analysis of TGF-β receptors I and II in active tuberculosis Infect. Immun. 72 2004 2628 2634
36. D. Dlugovitzky, M.L. Bay, L. Rateni, G. Fiorenza, L. Vietti, M.A. Farroni, and O.A. Bottasso Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB) Clin. Exp. Immunol. 122 2000 343 349
37. F.L. Cardoso, P.R. Antas, A.S. Milagres, A. Geluk, K.L. Franken, and E.B. Oliveira T-cell responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 in Brazilian tuberculosis patients Infect. Immun. 70 2002 6707 6714
38. N. Inokuchi, K. Sugahara, H. Soda, T. Usui, Y. Hirakata, and K. Fukushima Relationship between whole-blood interferon-gamma production and extent of radiographic disease in patients with pulmonary tuberculosis Diagn. Microbiol. Infect. Dis. 46 2003 109 114
39. R. Al-Attiyah, A.S. Mustafa, A.T. Abal, A.S. El-Shamy, W. Dalemans, and Y.A. Skeiky In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis Clin. Exp. Immunol. 138 2004 139 144
40. L. Tesfa, F.W. Koch, W. Pankow, H.D. Volk, and F. Kern Confirmation of Mycobacterium tuberculosis infection by flow cytometry after ex vivo incubation of peripheral blood T cells with an ESAT-6-derived peptide pool Cytometry 60B 2004 47 53
41. J.L. Flynn, M.M. Goldstein, J. Chan, K.J. Triebold, K. Pfeffer, and C.J. Lowenstein Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice Immunity 2 1995 561 572
42. V.P. Mohan, C.A. Scanga, K. Yu, H.M. Scott, K.E. Tanaka, and E. Tsang Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology Infect. Immun. 69 2001 1847 1855
43. J. Keane Tumor necrosis factor blockers and reactivation of latent tuberculosis Clin. Infect. Dis. 39 2004 300 302
44. A. Zganiacz, M. Santosuosso, J. Wang, T. Yang, L. Chen, and M. Anzulovic TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection J. Clin. Invest. 113 2004 401 413
45. Z. Toossi, M.E. Kleinhenz, and J.J. Ellner Defective interleukin-2 production and responsiveness in human pulmonary tuberculosis J. Exp. Med. 163 1986 1162 1172
46. V. Schauf, W.N. Rom, K.A. Smith, E.P. Sampaio, P.A. Meyn, and J.M. Tramontana Cytokine gene activation and modified responsiveness to interleukin-2 in the blood of tuberculosis patients J. Infect. Dis. 168 1993 1056 1059
47. J.L. Johnson, E. Ssekasanvu, A. Okwera, H. Mayanja, C.S. Hirsch, and J.G. Nakibali Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis Am. J. Respir. Crit. Care Med. 168 2003 185 191
48. E. Wildling, S. Winkler, P.G. Kremsner, C. Brandts, L. Jenne, and W.H. Wernsdorfer Malaria epidemiology in the province of Moyen Ogooú, Gabon Trop. Med. Parasitol. 46 1995 77 82
49. M. Ramharter, M. Willheim, H. Winkler, K. Wahl, H. Lagler, and W. Graninger Cytokine profile of Plasmodium falciparum-specific T cells in non-immune malaria patients Parasite Immunol. 25 2003 211 219
50. S. Winkler, M. Willheim, K. Baier, D. Schmid, A. Aichelburg, and W. Graninger Frequency of cytokine-producing T cells in patients of different age groups with Plasmodium falciparum malaria J. Infect. Dis. 179 1999 209 216
51. S.K. Schwander, M. Torres, E. Sada, C. Carranza, E. Ramos, and M. Tary-Lehmann Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis J. Infect. Dis. 178 1998 1434 1445
52. S.M. Barry, M.C. Lipman, B. Bannister, M.A. Johnson, and G. Janossy Purified protein derivative-activated type 1 cytokine-producing CD4+ T lymphocytes in the lung: a characteristic feature of active pulmonary and nonpulmonary tuberculosis J. Infect. Dis. 187 2003 243 250
53. X. Zhang, T. Brunner, L. Carter, R.W. Dutton, P. Rogers, and L. Bradley Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis J. Exp. Med. 185 1997 1837 1849
54. M.Y. Balkhi, A. Sinha, and K. Natarajan Dominance of CD86, transforming growth factor-β1, and interleukin-10 in Mycobacterium tuberculosis secretory antigen-activated dendritic cells regulates T helper 1 responses to mycobacterial antigens J. Infect. Dis. 189 2004 1598 1609
55. S.M. Fortune, A. Solache, A. Jaeger, P.J. Hill, J.T. Belisle, and B.R. Bloom Mycobacterium tuberculosis inhibits macrophage responses to IFN-δ through myeloid differentiation factor 88-dependent and -independent mechanisms J. Immunol. 172 2004 6272 6280
56. T.R. Malek, and A.L. Bayer Tolerance, not immunity, crucially depends on IL-2 Nat. Rev. Immunol. 4 2004 665 674
57. S.P. Hickman, J. Chan, and P. Salgame Mycobacterium tuberculosis induces differential cytokine production from dendritic cells and macrophages with divergent effects on naive T cell polarization J. Immunol. 168 2002 4636 4642
58. F.Q. Cunha, S. Moncada, and F.Y. Liew Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages Biochem. Biophys. Res. Commun. 182 1992 1155 1159
59. A.A. Awomoyi, A. Marchant, J.M. Howson, K.P. McAdam, J.M. Blackwell, and M.J. Newport Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis J. Infect. Dis. 186 2002 1808 1814
60. + T cells via ELISPOT in PBMC: cognate vs. nonspecific production of the cytokine J. Immunol. Methods 279 2003 111 121
61. + αβ T cell and γδ T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production J. Immunol. 154 1995 1786 1796